Literature DB >> 23458092

The COUP-TFII variant lacking a DNA-binding domain inhibits the activation of the Cyp7a1 promoter through physical interaction with COUP-TFII.

Tomoko Yamazaki1, Jun-ichi Suehiro, Hideki Miyazaki, Takashi Minami, Tatsuhiki Kodama, Kohei Miyazono, Tetsuro Watabe.   

Abstract

The COUP-TFII (chicken ovalbumin upstream promoter-transcription factor II) nuclear receptor, which is composed of a DNA-binding domain and a ligand-binding domain, exerts pleiotropic effects on development and cell differentiation by regulating the transcription of its target genes, including Cyp7a1 (cytochrome P450, family 7, subfamily a, polypeptide 1), which plays important roles in catabolism of cholesterol in the liver. Although multiple variants of COUP-TFII exist, their roles in the regulation of Cyp7a1 expression have not been elucidated. In the present study, we investigated the roles of COUP-TFII-V2 (variant 2), which lacks a DNA-binding domain, in the regulation of the transcriptional control of the Cyp7a1 gene by COUP-TFII in hepatocellular carcinoma cells. We found that COUP-TFII-V2 was significantly expressed in Huh7 cells, in which Cyp7a1 was not expressed. Furthermore, knockdown of COUP-TFII-V2 enhanced endogenous Cyp7a1 expression in Huh7 cells. Although COUP-TFII activates the Cyp7a1 promoter through direct binding to DNA, this activation was affected by COUP-TFII-V2, which physically interacted with COUP-TFII and inhibited its DNA-binding ability. Chromatin immunoprecipitation assays showed that COUP-TFII-V2 inhibited the binding of endogenous COUP-TFII to the intact Cyp7a1 promoter. The results of the present study suggest that COUP-TFII-V2 negatively regulates the function of COUP-TFII by inhibiting its binding to DNA to decrease Cyp7a1 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458092     DOI: 10.1042/BJ20121200

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

Review 1.  Nuclear receptors and pathogenesis of pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

2.  Fine mapping genetic variants associated with age at puberty and sow fertility using SowPro90 genotyping array.

Authors:  Hiruni R Wijesena; Stephen D Kachman; Clay A Lents; Jean-Jack Riethoven; Melanie D Trenhaile-Grannemann; Tim J Safranski; Matthew L Spangler; Daniel C Ciobanu
Journal:  J Anim Sci       Date:  2020-10-01       Impact factor: 3.159

Review 3.  COUP-TFII revisited: Its role in metabolic gene regulation.

Authors:  Usman M Ashraf; Edwin R Sanchez; Sivarajan Kumarasamy
Journal:  Steroids       Date:  2018-11-24       Impact factor: 2.668

4.  A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes.

Authors:  Verena Schwach; Arie O Verkerk; Mervyn Mol; Jantine J Monshouwer-Kloots; Harsha D Devalla; Valeria V Orlova; Konstantinos Anastassiadis; Christine L Mummery; Richard P Davis; Robert Passier
Journal:  Stem Cell Reports       Date:  2017-11-22       Impact factor: 7.765

5.  Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression.

Authors:  Simone Polvani; Sara Pepe; Sara Tempesti; Mirko Tarocchi; Giada Marroncini; Lapo Bencini; Elisabetta Ceni; Tommaso Mello; Lucia Picariello; Irene Simeone; Cecilia Grappone; Gabriele Dragoni; Lorenzo Antonuzzo; Elisa Giommoni; Stefano Milani; Andrea Galli
Journal:  Int J Oncol       Date:  2022-03-29       Impact factor: 5.650

6.  COUP-TFII regulates metastasis of colorectal adenocarcinoma cells by modulating Snail1.

Authors:  Y Bao; D Gu; W Feng; X Sun; X Wang; X Zhang; Q Shi; G Cui; H Yu; C Tang; A Deng
Journal:  Br J Cancer       Date:  2014-07-17       Impact factor: 7.640

Review 7.  COUP-TFII in Health and Disease.

Authors:  Simone Polvani; Sara Pepe; Stefano Milani; Andrea Galli
Journal:  Cells       Date:  2019-12-31       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.